SCHEMBL10360

SCHEMBL10360

CC(=O)N(C)c1nc(-c2ccc(F)cc2)c(C=O)c(C(C)C)n1

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP3A4 P08684 1/20 0.48
PDE6D O43924 1/20 0.48
NR1I2 O75469 1/20 0.48
PDE4D Q08499 1/20 0.48
ABCC3 O15438 1/20 0.46
ABCC4 O15439 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
GCGR P47871 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10129258 0.86 HMGCR (0.47) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL12617063 0.84 HMGCR (0.46) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL17965448 0.83 HMGCR (0.45) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL16070782 0.82 HMGCR (0.45) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL13538 0.82 HMGCR (0.61) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL12809951 0.81 ABCC3 (0.44) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL5698777 0.81 HMGCR (0.49) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL27607738 0.79 HMGCR (0.44) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL7920443 0.78 GCGR (0.43) HMGCRALDH1A1CYP3A4PDE6DNR1I2
SCHEMBL2574913 0.77 ABCC3 (0.80) HMGCRALDH1A1CYP3A4PDE6DNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE37314-E1 Pyrimidine derivatives SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 2001-08-07 US disclosed
US-5260440-A Anticholesterol agents SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1993-11-09 US disclosed
EP-0521471-A1 Pyrimidine derivatives as HMG-CoA reductase inhibitors SHIONOGI SEIYAKU KABUSHIKI KAISHA (JP) 1993-01-07 EP disclosed